The effect of selenium on anti TPO Ab in autoimmune hypothyroid patients

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180504039518N1

Enrollment

Registered

2018-08-12

Start date

2018-04-04

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune hypothyroidism. Other specified hypothyroidism

Interventions

Intervention 1: Intervention group: Take 200 Mcg selenium capsule per day for three months,the company that Manufactured it is Nature Made/USA and Take 100Mcg Levothyroxin per day that Manufactured

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: autoimmune hypothyroid patients who did not received thyroid Hormon since 3 month ago that referred to endocrinology clinic of Ghaem hospital

Exclusion criteria

Exclusion criteria: Acute Systemic Symptoms Renal failure Hepatic failure Malabsorption illness Use of Selenium Supplements over the past 6 months

Design outcomes

Primary

Measure	Time frame
Anti Thyroid Peroxidase. Timepoint: Before intervention, three months after intervention. Method of measurement: Electroluminescence Luminescence (ECL).	—

Secondary

Measure	Time frame
TSH. Timepoint: Before Intervention and 3 month after intervention. Method of measurement: Elisa kit lab.;Free T4. Timepoint: Before Intervention and 3 month after intervention. Method of measurement: Elisa kit lab.	—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactzahra jahani

Mashhad University of Medical Sciences

jahaniz901@mums.ac.ir+98 538012976

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026